IV drug use, dementia, and nursing home care for PWAs (persons with AIDS)

SOAR Repository

Show simple item record

dc.contributor Wichita State University. College of Health Professions en_US
dc.contributor.author Swan, James H. en_US
dc.contributor.author Benjamin, A. E. en_US
dc.date.accessioned 2012-03-02T16:13:34Z
dc.date.available 2012-03-02T16:13:34Z
dc.date.issued 1993 en_US
dc.identifier 10125467 en_US
dc.identifier 9000937 en_US
dc.identifier.citation Journal of health & social policy. 1993; 4(3): 79-91. en_US
dc.identifier.issn 0897-7186 en_US
dc.identifier.uri http://dx.doi.org/10.1300/J045v04n04_05 en_US
dc.identifier.uri http://hdl.handle.net/10057/4726
dc.description Click on the DOI link below to access the article (may not be free). en_US
dc.description.abstract Despite the usual focus on daily costs, because PWAs have higher costs per day than other SNF residents, LOS and days of care are important cost indices. Data on LOS for 102 admissions and annual days of care for 90 PWAs show average 64-day LOS and 67 days of care. Regression analysis and survival analysis show dementias and IV drug use to mean longer LOS and more days of care. Higher PWA costs must be sustained over longer periods for PWAs with dementias and for IV drug users, who may claim increasing shares of the SNF care provided to PWAs. en_US
dc.format.extent 79-91 en_US
dc.language.iso eng en_US
dc.publisher Routledge en_US
dc.relation.ispartofseries Journal of Health & Social Policy en_US
dc.relation.ispartofseries J Health Soc Policy en_US
dc.source NLM en_US
dc.subject Research Support, Non-U.S. Gov't en_US
dc.subject Review en_US
dc.subject.mesh Acquired Immunodeficiency Syndrome/economics en_US
dc.subject.mesh California en_US
dc.subject.mesh Data Collection en_US
dc.subject.mesh Dementia/economics en_US
dc.subject.mesh Evaluation Studies as Topic en_US
dc.subject.mesh Health Care Costs/statistics & numerical data en_US
dc.subject.mesh Health Services Needs and Demand/economics en_US
dc.subject.mesh Humans en_US
dc.subject.mesh Length of Stay/economics en_US
dc.subject.mesh Medicaid/economics en_US
dc.subject.mesh Regression Analysis en_US
dc.subject.mesh Skilled Nursing Facilities/economics en_US
dc.subject.mesh Substance Abuse, Intravenous/economics en_US
dc.subject.mesh United States en_US
dc.subject.mesh Acquired Immunodeficiency Syndrome/nursing en_US
dc.subject.mesh Dementia/nursing en_US
dc.subject.mesh Length of Stay/statistics & numerical data en_US
dc.subject.mesh Skilled Nursing Facilities/statistics & numerical data en_US
dc.subject.mesh Skilled Nursing Facilities/utilization en_US
dc.subject.mesh Substance Abuse, Intravenous/nursing en_US
dc.title IV drug use, dementia, and nursing home care for PWAs (persons with AIDS) en_US
dc.type Article en_US
dc.coverage.spacial United States en_US
dc.description.version peer reviewed en_US
dc.rights.holder Copyright © Routledge en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search SOAR

Advanced Search


My Account